Ledipasvir, sofosbuvir drug combination
Showing 9976 - 10000 of >10,000
Postoperative Pain Trial in Pasadena, Bellaire (Pregabalin, Acetaminophen, Placebo 1)
Hepatocellular Carcinoma Trial in Beijing (HAIC, TACE, FOLFOX)
Recruiting
- Hepatocellular Carcinoma
- HAIC
- +4 more
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 10, 2022
Refractory T-Cell Lymphoma, Relapsed T-Cell Lymphoma Trial in Italy (Daratumumab)
Active, not recruiting
- Refractory T-Cell Lymphoma
- Relapsed T-Cell Lymphoma
-
Bari, Italy
- +6 more
Aug 1, 2022
Mucosal Melanoma of the Head and Neck Trial in Saint Louis (Pembrolizumab, Hypofractionated radiation therapy)
Recruiting
- Mucosal Melanoma of the Head and Neck
- Pembrolizumab
- Hypofractionated radiation therapy
-
Saint Louis, MissouriWashington University School of Medicine
Feb 7, 2022
Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies
Recruiting
- High Risk Pregnancy
- +2 more
- Arterial Stiffness and Wave Reflection
-
Montreal, Quebec, CanadaRoyal Victoria Hospital
Jun 7, 2022
Hypertension Trial in Paris (APN intervention)
Not yet recruiting
- Hypertension
- APN intervention
-
Paris, IDF, FranceDiagnosis and Therapeutic Center, Hôtel-Dieu Hospital
Jun 14, 2023
Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in
Active, not recruiting
- Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 20, 2023
Epileptic Seizures Trial in France (MRI)
Completed
- Epileptic Seizures
- MRI
-
Marseille, France
- +3 more
Oct 26, 2022
Coronary Artery Disease Trial in Belgium, New Zealand (Percutaneous Coronary Intervention with drug eluting stents)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention with drug eluting stents
-
Antwerp, Belgium
- +7 more
Mar 11, 2022
Diarrhea Caused by Antitumor Drugs Trial in Tianjin (Traditional Chinese Medicine)
Recruiting
- Diarrhea Caused by Antitumor Drugs
- Traditional Chinese Medicine
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Aug 3, 2021
Hepatocellular Carcinoma Trial in Seoul (Durvalumab, Radioembolization)
Active, not recruiting
- Hepatocellular Carcinoma
- Durvalumab
- Radioembolization
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 23, 2021
Heart Transplant Surgery, Lung Transplant Surgery Trial in Durham (iNO, iEPO)
Completed
- Heart Transplant Surgery
- Lung Transplant Surgery
-
Durham, North CarolinaDuke Health
Feb 14, 2022
Cerebral Stroke, Thrombosis, Deep Vein, Pulmonary Embolism Trial
Withdrawn
- Cerebral Stroke
- +2 more
- (no location specified)
Nov 14, 2021
Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)
Recruiting
- Hepatitis B, Chronic
- ASC42 10mg
- +4 more
-
Guangzhou, Guangdong, ChinaNanFang Hospital of Southern Medical University
Jan 13, 2022
Pancreas Cancer Trial in Louisville (Irreversible Electroporation (IRE), Gemcitabine, FOLFIRINOX)
Recruiting
- Pancreas Cancer
- Irreversible Electroporation (IRE)
- +2 more
-
Louisville, KentuckyUniversity of Louisville
Oct 6, 2021
Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2023
Pectus Excavatum Trial in Brisbane (PCL Pectus Scaffold implantation and autologous fat grafting)
Recruiting
- Pectus Excavatum
- PCL Pectus Scaffold implantation and autologous fat grafting
-
Brisbane, Queensland, AustraliaPrincess Alexandra Hospital - Wooloongabba
Nov 17, 2022
Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)
Terminated
- Neuroblastoma Recurrent
- Naxitamab and GM-CSF in combination with irinotecan and temozolomide
-
Hong Kong, Hong Kong
- +2 more
Nov 8, 2022
Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)
Terminated
- Solid Tumor
- Unresectable or Metastatic Melanoma
-
Duarte, California
- +26 more
Nov 2, 2021
Implementation ofNovel Functional Eye-Tracking Biomarker for
Recruiting
- Clinically Isolated Syndrome
- Relapsing Remitting Multiple Sclerosis
- Eye-tracking
-
Montréal, Quebec, CanadaMontreal Neurological Institute and Hospital
Sep 2, 2022
Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)
Recruiting
- Cholangiocarcinoma
- Combination of Lonsurf® and Irinotecan
-
Düsseldorf, NRW, GermanyKlinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022